Picard Medical is trading 5.5% lower at $12.12 after-hours; no verified company-specific announcement explains the decline.
- Shares closed the October 16 regular session at $12.83. The latest reported company news was an October 7 bylaw change, not a new October 16 catalyst.
- In the supplied market context, the Nasdaq fell 2.12% and the S&P 500 fell 1.16%. The broad sell-off is a plausible contributor, but the cause of Picard Medicalβs move is unconfirmed.